Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b295364746e816ef06c8a4964173bf4c http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f2d3599fb8f8f479dba95ca9bb504884 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1158a821d831793b30411a45096117a7 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_867e0694ff27da8bf845a046bd3b2134 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-98 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2500-04 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-34 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N9-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-34 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-52 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/B01D1-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/B01D- http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-92 |
filingDate |
2003-10-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7cc15441ff1a25c636dd33afc961ba1c http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a75dc1e7f6acfc5acc73245a9adf9dfb http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6ab5eee6eb1ccec1ae152078b206af47 |
publicationDate |
2006-08-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
WO-2004037371-A3 |
titleOfInvention |
Assay for determining the activity of fatty acid amide hydrolase |
abstract |
The invention provides methods of assaying fatty acid amide hydrolase (FAAH) activity adaptable for high throughput screening. The methods provide for separating a labeled substrate from at least one labeled hydrolysis product, the separation facilitating the quantification. The invention also provides methods of identifying a compound to be tested as an inhibitor or an activator of FAAH activity through the addition of the compound to be tested to a reaction mixture and comparison of the enzyme activity in the presence and absence of the compounds to be tested. The methods are adaptable for use in detecting altered FAAH activity in patients, for example, those at risk for in vitro fertilization failure, or at risk for, or suffering, addictions. |
priorityDate |
2002-10-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |